Mickie Takagi

Prof. Dr. Mickie Takagi

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
Viviane Maimoni GoncalvesViviane Maimoni Goncalves
Viviane Maimoni Goncalves
Viviane Maimoni GoncalvesViviane Maimoni Goncalves
Viviane Maimoni Goncalves
MTMickie Takagi
Mickie Takagi
RLRodrigo B. Lima
Rodrigo B. Lima
HMHugo Massaldi
Hugo Massaldi
MTMartha M. Tanizaki
Martha M. Tanizaki

1 October 2006 in FEMS Immunology & Medical Microbiology
Verified
Journal Article
Open access
PDF file
MLMelissa Ang Simãµes Lasaro
Melissa Ang Simãµes Lasaro
JRJuliana Falcã£O Rodrigues
Juliana Falcã£O Rodrigues
CMCamila Mathias-Santos
Camila Mathias-Santos
BGBeatriz E. C. Guth
Beatriz E. C. Guth
ARAdriana Rã©Gua-Mangia
Adriana Rã©Gua-Mangia
LFLuís Ferreira
Luís Ferreira
Production and release of heat-labile toxin (LT) by wild-type enterotoxigenic Escherichia coli (ETEC) strains, isolated from diarrheic and asymptomat

1 June 2008 in Vaccine
Verified
Journal Article
Closed access
FCFátima C.L. Csordas
Fátima C.L. Csordas
CPCátia T. Perciani
Cátia T. Perciani
MDMichelle Darrieux
Michelle Darrieux
Viviane Maimoni GoncalvesViviane Maimoni Goncalves
Viviane Maimoni Goncalves
JCJoaquim Cabrera-Crespo
Joaquim Cabrera-Crespo
MTMartha M. Tanizaki
Martha M. Tanizaki

20 August 2008 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MTMickie Takagi
Mickie Takagi
RLRodrigo Barbosa Lima
Rodrigo Barbosa Lima
SASilvia Maria Ferreira Albani
Silvia Maria Ferreira Albani
TZTeresa Cristina Zangirolami
Teresa Cristina Zangirolami
MTMartha Massako Tanizaki
Martha Massako Tanizaki
JCJoaquin Cabrera-Crespo
Joaquin Cabrera-Crespo
Haemophilus influenzae type b, an encapsulated bacterium, causes meningitis in infants worldwide. The capsular polysaccharide conjugated to a carrier protein is effective in the prevention of such infections. The traditional purification process of polysaccharide from bacterial cultures for vaccine production is based on several selective precipitations with solvents such as: ethanol, phenol, and cationic detergents. The separations of solid and liquid phases are based on continuous centrifugation in explosion proof installations. The lipopolysaccharides are separated by ultracentrifugation. A simple and efficient method that can easily be scaled-up was developed for purification of polysaccharides. The ethanol precipitation was reduced to only two steps. The phenol treatment was substituted by ultrafiltration and enzymatic digestion. Lipopolysaccharide was removed by ultrafiltration together with addition of detergent and chelating agent.

20 August 2008 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
CLC. Liberman
C. Liberman
MTMickie Takagi
Mickie Takagi
JCJ. Cabrera-Crespo
J. Cabrera-Crespo
MSM. E. Sbrogio-Almeida
M. E. Sbrogio-Almeida
WDW. O. Dias
W. O. Dias
Viviane Maimoni GoncalvesViviane Maimoni Goncalves
Viviane Maimoni Goncalves
The high cost of the available pneumococcal conjugated vaccines has been an obstacle in implementing vaccination programs for children in developing countries. As an alternative, Malley et al. proposed a vaccine consisting of inactivated whole-cells of unencapsulated S. pneumoniae, which provides serotype-independent protection and involves lower production costs. Although the pneumococcus has been extensively studied, little research has focused on its large-scale culture, thus implying a lack of knowledge of process parameters, which in turn are essential for its successful industrial production. The strain Rx1Al− eryR was originally cultured in Todd–Hewitt medium (THY), which is normally used for pneumococcus isolation, but is unsuitable for human vaccine preparations. The purposes of this study were to compare the strains Rx1Al− eryR and kanR, develop a new medium, and generate new data parameters for scaling-up the process. In static flasks, cell densities were higher for eryR than kanR. In contrast, the optical density (OD) of the former decreased immediately after reaching the stationary phase, and the OD of the latter remained stable. The strain Rx1Al− kanR was cultivated in bioreactors with medium based on either acid-hydrolyzed casein (AHC) or enzymatically hydrolyzed soybean meal (EHS). Biomass production in EHS was 2.5 times higher than in AHC, and about ten times higher than in THY. The process developed for growing the strain Rx1Al− kanR in pH-controlled bioreactors was shown to be satisfactory to this fastidious bacterium. The new culture conditions using this animal-free medium may allow the production of the pneumococcal whole-cell vaccine.

23 September 2005 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Closed access
PDF file
MTMickie Takagi
Mickie Takagi
JCJoaquin Cabrera‐Crespo
Joaquin Cabrera‐Crespo
TZTeresa Cristina Zangirolami
Teresa Cristina Zangirolami
IRIsaias Raw
Isaias Raw
MTMartha Massako Tanizaki
Martha Massako Tanizaki